For those who have been suffering from the torture of addiction problems and those who want to have something which can actually be a help to them in dealing with addiction problems, there is simply not a single speck of doubt that having Suboxone is going to be the best bet that people tend to make for sure.
With Suboxone treatment doctors Providence, there will not be any doubts in the minds of the patients who might require some help. Being a part of the Suboxone treatment program might just be a very good idea.
There are so many people who want to make a new life and want to leave the life of addiction. For them, having a chat with the Suboxone doctor Providence is going to be the best thing for sure. Book an appointment with us to see what we have to offer you right here.
The Suboxone doctors in Providence have taken the onus to relieve patients from their substance addiction and involve them in therapy, counseling, and support. It is essential for the patients to slowly develop positive changes in their lives, which guide them towards sustained addiction remission and long-term sobriety.
Suboxone is an effective combination of Buprenorphine and Naloxone. While Naloxone has been long considered as the first line of defense against overdoses caused due to opioid abuse, Buprenorphine is one of the top medication choices to treat Opioid Use Disorder (OUD). The highest authority in the country- Food and Drug Administration (FDA) of the US approves of Buprenorphine and Suboxone as an essential medication that forms a part of medication-assisted treatment (MAT) and should be prescribed as a part of an exhaustive treatment plan, including counseling and holistic behavioral cum cognitive therapies.
The Drug Addiction Treatment Act issued in 2000 (DATA 2000), the Comprehensive Addiction and Recovery Act (CARA) and the Substance Use-Disorder Prevention Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act allows qualified and licensed medical practitioners, equipped with specialized training, to dispense or prescribe Buprenorphine for OUD treatment other than opioid treatment programs (OTP).
No. Suboxone is a vital maintenance medication used in MAT and IOP but should not be mistaken for a drug substitution. Since Suboxone has a revolutionary formulation consisting of the partial opioid agonist-Buprenorphine, and the opioid antagonist-Naloxone, it does not create any euphoric or pleasurable feeling that is typically associated with a ‘drug high.’ The Buprenorphine creates a ceiling effect on the analgesic behaviors over the CNS upon increased dosage, whereas the Naloxone binds at specific opioid receptor sites, inhibiting euphoria, and respiratory depression.
Because of the exhibition of a ceiling effect on the administration of greater dosage, Buprenorphine is a much safer medication for OUD treatment in patients. Since it is the chief component of Suboxone, hence Suboxone has become a more potent medication to treat OUD in patients than Methadone.
Thus Buprenorphine is much safer to use than Methadone, is more comfortable to prescribe, and hence does not require daily visits.
It is imperative not to start the Suboxone/ Buprenorphine treatment program if the patient has used the drugs on the same day. Doctors and medical experts prefer that the patient be in withdrawal when taking the first dosage of Buprenorphine or starting the program. When the patient is in withdrawal, mild or moderate, the opioid receptor sites in the brain are devoid of opioids and are craving them. These are the sites where the Buprenorphine will go and latch on. If the person has used drugs the day they want to start the program, most of the Buprenorphine will not find any opioid receptor sites to attach themselves. Since Buprenorphine is more potent than illicit opiates and opioids, it will throw those chemicals out of those sites, thereby causing a violent, 'precipitated withdrawal'.
The frequency of the doctor visits is up to the doctor. Most doctors prefer a couple of visits in the first week of the program, whereas they are content with a single visit from the patient in the following weeks. The doctors need to be careful about the correct dosage and have confidence in the patient's self-administration of the medication, upon which they might decrease the frequency of visits.